Cargando…

Clinical trials with anti-angiogenic agents in hematological malignancies

New blood vessel formation (angiogenesis) is not only essential for the growth of solid tumors but there is also emerging evidence that progression of hematological malignancies like multiple myeloma, acute leukemias, and myeloproliferative neoplasms, also depends on new blood vessel formation. Anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Medinger, Michael, Mross, Klaus
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902424/
https://www.ncbi.nlm.nih.gov/pubmed/20569499
http://dx.doi.org/10.1186/2040-2384-2-10